Overcoming Barriers to Metabolic Monitoring in Youth Treated With SGAs

<p>In this episode, we focus on the challenges faced in metabolic monitoring of youth receiving second-generation antipsychotics (SGAs), including the strategies to overcome these barriers and ensure the long-term health of young patients on SGAs.</p> <p>Faculty: David Rosenberg, M.D.<br /> Host: Richard Seeber, M.D.</p> <ul> <li><a href= "https://psychopharmacologyinstitute.com/cme-program?section=pricing&utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC239" target="_blank" rel="noopener"><strong>Learn more about our membership here</strong></a></li> <li><a href= "https://psychopharmacologyinstitute.com/publication/cap-smart-takes-vol-06-2745?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC239" target="_blank" rel="noopener"><strong>Earn 0.5 CMEs: CAP Smart Takes Vol. 06</strong></a></li> <li><a href= "https://psychopharmacologyinstitute.com/section/barriers-to-metabolic-monitoring-of-sgas-in-youth-2745-5373?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC239" target="_blank" rel="noopener"><strong>Barriers to Metabolic Monitoring of SGAs in Youth</strong></a></li> </ul>